Hämato-Onkologie Hamburg, Prof. Laack und Partner

Hamburg 3 trials

3 Registered trials

0 Currently recruiting

Organisation

Hämato-Onkologie Hamburg, Prof. Laack und Partner

Location

Hamburg, Germany

Identifier

ORL-000003434

Address

Lehmweg 7, Standort Hoheluft, 20251, Germany

Departments

N/A
Oncology
Standort Hoheluft

Clinical trials at this site (3)

Search interface

A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC Ended

2023-504753-12-00 Lung Cancer, Non-Small Cell 5 2024-10-01
A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered i… Ended

2023-506696-10-00 Non-Small Cell Lung Cancer 5 2024-06-18
A randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC af… Ended

2023-509137-39-00 Stage IB (T ≥ 4 cm), II and IIIA NSCLC 5 2015-11-06